These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 8175018

  • 1. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
    Del Campo JM, Felip E, Rubio D, Vidal R, Bermejo B, Colomer R, Zanon V.
    Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
    [Abstract] [Full Text] [Related]

  • 2. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR.
    Anticancer Res; 2000 Apr; 20(3B):1959-64. PubMed ID: 10928134
    [Abstract] [Full Text] [Related]

  • 3. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G.
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [Abstract] [Full Text] [Related]

  • 4. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
    Bolis G, Villa A, Guarnerio P, Ferraris C, Gavoni N, Giardina G, Melpignano M, Scarfone G, Zanaboni F, Parazzini F.
    Cancer; 1996 Jan 01; 77(1):128-31. PubMed ID: 8630918
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 6. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gérard JP, Romestaing P, Carrie C.
    Gynecol Oncol; 2007 Jan 15; 104(1):104-8. PubMed ID: 16987544
    [Abstract] [Full Text] [Related]

  • 7. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
    Ojeda B, Llanos M, Brunet J, Lacasta A, Alonso MC, Rueda A, Delgado E, Badía J, López López JJ.
    Med Clin (Barc); 1995 Feb 11; 104(5):165-9. PubMed ID: 7877374
    [Abstract] [Full Text] [Related]

  • 8. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
    Huang X, Cai SM, Tang J, Li ZT, Zang RY.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep 11; 39(9):602-5. PubMed ID: 15498187
    [Abstract] [Full Text] [Related]

  • 9. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE.
    Gynecol Oncol; 1994 Dec 11; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [Abstract] [Full Text] [Related]

  • 10. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug 11; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

  • 11. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 Aug 11; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C, Louvet C, Molitor JL, Dehni N, Lejeune V, Sezeur A, Pigne A, Marpeau L, Cady J, de Gramont A.
    Gynecol Oncol; 2001 Nov 11; 83(2):198-204. PubMed ID: 11606072
    [Abstract] [Full Text] [Related]

  • 15. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.
    Bone Marrow Transplant; 2000 Jul 11; 26(1):61-7. PubMed ID: 10918406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute].
    Pautier P, Rey A, Michel G, Castaigne D, Rochard F, Duvillard P, Haie-Meder C, Curcio P, Benedetti-Richard L, Lhommé C.
    Bull Cancer; 1997 Feb 11; 84(2):147-54. PubMed ID: 9180837
    [Abstract] [Full Text] [Related]

  • 19. Gynecological malignancies.
    Schaebler DL, Schilder RJ, Young RC.
    Cancer Chemother Biol Response Modif; 1996 Feb 11; 16():564-91. PubMed ID: 8639401
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.